Literature DB >> 12773060

Factors affecting patient adherence to highly active antiretroviral therapy.

Ismael Escobar1, Mercedes Campo, Jesus Martín, Clara Fernández-Shaw, Federico Pulido, Rafael Rubio.   

Abstract

OBJECTIVE: To determine the clinical and demographic variables related to adherence to highly active antiretroviral therapy (HAART) in patients treated in our hospital and identify the characteristics of nonadherent patients.
METHODS: Outpatients receiving treatment with HAART (n = 283) were asked about variables related to adherence and to complete the APGAR (family support), State-Trait Anxiety questionnaire (STAI) (emotional situation), and IAS (social support) questionnaires. Patients were classified in 2 groups depending on whether adherence was > or =95% or <95%. Adherence was defined as the percentage of dosage forms prescribed that were obtained by the patient at the hospital pharmacy. A multivariate analysis was created to analyze how each significant variable affected adherence.
RESULTS: Our data showed significant nonadherence for patients with the following factors: low level of education, unemployed, emotional situation, and abuse of substances including intravenous drugs. All significant variables were included in a logistic regression model to optimize the results. This model considered 4 variables: age (95% CI 0.89 to 0.99), number of antiretroviral drugs (95% CI 1.05 to 2.11), STAI Anxiety/Trait test (95% CI 2.02 to 6.02), and abuse of drugs (95% CI 1.20 to 3.95).
CONCLUSIONS: We recommended special intervention to reinforce adherence for younger patients, patients taking a high number of antiretroviral drugs, those who have a history of intravenous drug use, and those with high anxiety status.

Entities:  

Mesh:

Year:  2003        PMID: 12773060     DOI: 10.1345/aph.1C427

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  8 in total

1.  Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment.

Authors:  Karl Goodkin; Benedetto Vitiello; William D Lyman; Deshratn Asthana; J Hampton Atkinson; Peter N R Heseltine; Rebeca Molina; Wenli Zheng; Imad Khamis; Frances L Wilkie; Paul Shapshak
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

2.  Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort.

Authors:  Matthew E Levy; Anne K Monroe; Michael A Horberg; Debra A Benator; Sherry Molock; Rupali K Doshi; Lindsey Powers Happ; Amanda D Castel
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

3.  Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.

Authors:  Stéphane Corvaisier; Bruno Charpiat; Cyril Mounier; Martine Wallon; Gilles Leboucher; Mounzer Al Kurdi; Jean-François Chaulet; François Peyron
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Monocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts.

Authors:  Roger D Rossen; Jose A Rubio; Wendy J Porter; JoAnn Trial; Frank M Orson; Maria C Rodriguez-Barradas; Holly H Birdsall
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

Review 5.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.

Authors:  Sandra A Springer; Azem Dushaj; Marwan M Azar
Journal:  AIDS Behav       Date:  2012-11

7.  Adherence: a review of education, research, practice and policy in Spain.

Authors:  Narjis Fikri-Benbrahim; Victoria García-Cárdenas; Loreto Sáez-Benito; Miguel A Gastelurrutia; María P Faus; Marie P Schneider; Parisa Aslani
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

8.  Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).

Authors:  Awoke Seyoum; Principal Ndlovu; Zewotir Temesgen
Journal:  AIDS Res Ther       Date:  2017-03-16       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.